Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 7NIH 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Lymphoid 1

Conditions

Multiple Myeloma 207Neoplasms, Plasma Cell 73Lymphoma 71Lymphoma, Non-Hodgkin 48Leukemia, Lymphocytic, Chronic, B-Cell 47Precursor Cell Lymphoblastic Leukemia-Lymphoma 42Leukemia 37Hodgkin Disease 37Lymphoma, Follicular 36Lymphoma, Mantle-Cell 35Lymphoma, Large B-Cell, Diffuse 35Hematologic Neoplasms 34Leukemia, Myeloid, Acute 33Lymphoma, B-Cell, Marginal Zone 32Burkitt Lymphoma 32Myelodysplastic Syndromes 31Lymphoma, Large-Cell, Immunoblastic 31Myeloproliferative Disorders 26Leukemia, Myeloid, Chronic-Phase 22Leukemia, Myeloid, Accelerated Phase 22Blast Crisis 21Lymphoma, T-Cell, Cutaneous 19Leukemia, Hairy Cell 19Primary Myelofibrosis 18Waldenstrom Macroglobulinemia 17Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 17Leukemia, Myelomonocytic, Chronic 16Sezary Syndrome 15Mycosis Fungoides 15Lymphoma, Large-Cell, Anaplastic 15

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Cytokine Release Syndrome × Plasma cell × Clear all
NCT07499128 2026-06-01

Continuous Temperature Monitoring (CTM) for Cytokine Release Syndrome (CRS), an Immune-Related Adverse Event

National Institutes of Health Clinical Center (CC)

Phase NA Enrolling by invitation
136 enrolled
LymphoidOther hematologic neoplasmPlasma cell

Cytokine Release Syndrome, Lymphoma, Multiple Myeloma, Neoplasms, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡